In view of the fact that the high expression of BAG2 associates with poor prognosis in patients with gastric cancer and that is related to several clinicopathological characteristics, we further analyzed the prognosis of high/low expression of BAG2 in different clinicopathological subgroups. The gene discussed is BAG2; the disease is gastric cancer.